Published in Physician Law Weekly, August 15th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Diamyd Medical.
Report 1: Diamyd Medical reports that the Company plans to apply to continue the study in 160 LADA patients, which was invalidated after concerns of a mix up between active drug and placebo. After deliberations with Professors 'ke Lernmark and Carl-David Agardh at Malmo University Hospital, Sweden, it was concluded that the study can still bring valuable information. Completing the study does not involve any material extra costs for the Company.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Physician Law Weekly